Bragar Eagel & Squire, P.C. reminds investors that a class action lawsuit has been filed against Phreesia, Inc. and the lead plaintiff deadline is July 13, 2026. The lawsuit covers purchasers of Phreesia common stock between May 8, 2025 and March 30, 2026. The complaint alleges the company made false or misleading statements and failed to disclose slowing demand and reduced visibility in key revenue streams, particularly weakened pharmaceutical marketing commitments in its Network Solutions segment. On March 30, 2026, Phreesia reduced its fiscal 2027 revenue guidance to $510 million to $520 million, down $35 million to $49 million from the prior range, citing those factors, and the stock fell 21 to 28 percent on the revised outlook. Investors who suffered losses can contact the firm to discuss their legal rights.
Phreesia IncClass action lawsuit alleges Phreesia failed to disclose slowing demand and reduced visibility in key revenue streams, particularly weakened pharmaceutical marketing commitments, leading to lowered guidance and stock drop.